- Home
- AAUC vs AGIO Comparison
AAUC vs AGIO Comparison
Compare AAUC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAUC
- AGIO
- Stock Information
- Founded
- AAUC N/A
- AGIO 2007
- Country
- AAUC Canada
- AGIO United States
- Employees
- AAUC N/A
- AGIO N/A
- Industry
- AAUC
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- AAUC
- AGIO Health Care
- Exchange
- AAUC Nasdaq
- AGIO Nasdaq
- Market Cap
- AAUC 1.5B
- AGIO 1.4B
- IPO Year
- AAUC N/A
- AGIO 2013
- Fundamental
- Price
- AAUC $12.71
- AGIO $37.54
- Analyst Decision
- AAUC
- AGIO Buy
- Analyst Count
- AAUC 0
- AGIO 6
- Target Price
- AAUC N/A
- AGIO $57.40
- AVG Volume (30 Days)
- AAUC 67.0K
- AGIO 683.9K
- Earning Date
- AAUC 08-08-2025
- AGIO 07-31-2025
- Dividend Yield
- AAUC N/A
- AGIO N/A
- EPS Growth
- AAUC N/A
- AGIO N/A
- EPS
- AAUC N/A
- AGIO 11.45
- Revenue
- AAUC $901,722,000.00
- AGIO $37,035,000.00
- Revenue This Year
- AAUC $68.13
- AGIO $22.30
- Revenue Next Year
- AAUC $32.41
- AGIO $219.19
- P/E Ratio
- AAUC N/A
- AGIO $3.29
- Revenue Growth
- AAUC 33.30
- AGIO 25.96
- 52 Week Low
- AAUC $12.69
- AGIO $23.42
- 52 Week High
- AAUC $15.79
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- AAUC N/A
- AGIO 50.29
- Support Level
- AAUC N/A
- AGIO $37.09
- Resistance Level
- AAUC N/A
- AGIO $40.80
- Average True Range (ATR)
- AAUC 0.00
- AGIO 1.53
- MACD
- AAUC 0.00
- AGIO -0.45
- Stochastic Oscillator
- AAUC 0.00
- AGIO 9.68
About AAUC Allied Gold Corporation Common Shares
Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, the development of new mines, the advancement of its exploration properties, and, targeting other consolidation opportunities with a focus on Africa.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.